InMode Q2 revenue beats estimates on steady U.S. demand
InMode Q2 revenue beats estimates on steady U.S. demand
Overview
Israel medical device maker's Q2 revenue was flat yr/yr but beat analyst expectations
Q2 net income, operating income, and pretax profit all missed analyst estimates
Company completed $87.8 mln share buyback during the quarter
Outlook
InMode expects 2026 revenue between $365 mln and $375 mln
Company sees 2026 non-GAAP gross margin between 74% and 76%
InMode expects 2026 non-GAAP EPS between $1.29 and $1.34
Result Drivers
STEADY U.S. DEMAND - Co said U.S. capital equipment business remained stable, reflecting steady customer demand
ASIA GROWTH - Revenue from Asia reached a quarterly record, reflecting continued strength across key markets in the region
HIGHER COSTS AND EXPENSES - Co said lower margins were due to higher cost of goods sold, product mix, sales team restructuring, increased marketing and sales investments, and higher general and administrative expenses
Company press release: ID:nPn5jqGl0a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $95.59 mln | $93.03 mln (5 Analysts) |
Q2 Net Income | Miss | $17.06 mln | $20.23 mln (4 Analysts) |
Q2 Income from Operations | Miss | $12.26 mln | $18.11 mln (5 Analysts) |
Q2 Pretax Profit | Miss | $19.69 mln | $23.10 mln (3 Analysts) |
Q2 Operating Expenses |
| $59.26 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for InMode Ltd. is $15.00, about 2.4% below its August 4 closing price of $15.37
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago
Reuters Recommended Reads
Aug 4 - Sofwave Medical's Q2 revenue rises on usage fee growth
Aug 3 - KKR to take medical-equipment maker Integer Holdings private in $5.7 billion deal
Aug 3 - Inspire Medical Q2 revenue falls less than expected
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting